PPP1R12A and Hypertension: Small molecules could be designed to modulate either total MYPT1 or LZ+ MYPT1 expression in vascular smooth muscle, and therapies designed to increase LZ+ MYPT1 expression in vascular smooth muscle would improve both the vascular response to endogenous NO and pharmacological response during the treatment of hypertension.